Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BioCardia, Inc. Director's Dealing 2019

Jan 3, 2019

35081_dirs_2019-01-03_02be17d2-6797-4ce1-8259-540c62392641.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BioCardia, Inc. (BCDA)
CIK: 0000925741
Period of Report: 2018-12-24

Reporting Person: Stertzer Kimberly (10% Owner)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 4278274 Indirect
Common Stock 2076346 Indirect
Common Stock 12000 Direct
Common Stock 104910 Indirect
Common Stock 448895 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Warrant (Right to Buy) $0.7500 2023-12-24 Common Stock (833333) Indirect
Warrant (Right to Buy) $0.7500 2023-12-24 Common Stock (833333) Indirect

Footnotes

F1: The Reporting Person and her spouse are co-trustees of the Stertzer Family Trust, and share voting and dispositive control over the securities held by the Stertzer Family Trust

F2: The Reporting Person and her spouse are the sole members and managers of Windrock Enterprises L.L.C., and share voting and dispositive control over the securities held by Windrock Enterprises L.L.C.

F3: Owned jointly with Simon H. Stertzer

F4: These shares are held by the Stertzer Gamma Trust, of which the Reporting Person is the grantor.

F5: These shares are held by Stertzer Holdings LLC. The Reporting Person is a manager of Stertzer Holdings LLC and has voting and dispositive control of such shares.